SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer
Abstract Abnormal lipid metabolism has been commonly observed in various human cancers, including colorectal cancer (CRC). The mitochondrial citrate carrier SLC25A1 (also known as mitochondrial citrate/isocitrate carrier, CIC), has been shown to play an important role in lipid metabolism regulation....
Guardado en:
Autores principales: | Ying Yang, Jiaxing He, Bo Zhang, Zhansheng Zhang, Guozhan Jia, Shiqi Liu, Tao Wu, Xianli He, Nan Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6db171886afe41f0ab51c2f34d80bf9b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1α in colorectal cancer
por: Xin Zhang, et al.
Publicado: (2021) -
Direct reprogramming of adult cells: avoiding the pluripotent state
por: Kelaini S, et al.
Publicado: (2014) -
Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells
por: Chen Wang, et al.
Publicado: (2021) -
HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer
por: Jie Xu, et al.
Publicado: (2021) -
Metformin Corrects Glucose Metabolism Reprogramming and NLRP3 Inflammasome-Induced Pyroptosis via Inhibiting the TLR4/NF-κB/PFKFB3 Signaling in Trophoblasts: Implication for a Potential Therapy of Preeclampsia
por: Yang Zhang, et al.
Publicado: (2021)